Q3 2016 Holdings
Filed 2016-11-15 | 51 holdings | $88.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $39.0M | 737,900 | 44.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $25.5M | 1,072,638 | 28.9% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $11.2M | 714,692 | 12.7% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $10.6M | 127,106 | 12.0% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $565.0K | 187,610 | 0.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $212.0K | 677 | 0.2% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $112.4K | 16,658,072 | 0.1% |
| Seattle Genetics Inc | COM | 812578102 | $96.2K | 1,781,470 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $94.4K | 12,751,536 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $73.9K | 2,049,985 | 0.1% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $72.5K | 545,922 | 0.1% |
| Incyte Corp(INCY) | COM | 45337C102 | $56.4K | 597,638 | 0.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $51.1K | 672,918 | 0.1% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $45.4K | 778,160 | 0.1% |
| Endologix Inc | COM | 29266S106 | $44.6K | 3,480,644 | 0.1% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $44.4K | 662,286 | 0.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $43.2K | 2,021,617 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $42.1K | 701,659 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $39.3K | 640,400 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $31.1K | 464,077 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $29.3K | 2,138,471 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $24.7K | 1,237,435 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $23.7K | 227,267 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $23.3K | 505,154 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $23.0K | 702,539 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $22.8K | 701,822 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $20.8K | 916,927 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $18.0K | 1,431,119 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $17.8K | 3,214,946 | 0.0% |
| Model N Inc(MODNEUR) | COM | 607525102 | $17.2K | 1,550,959 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $14.9K | 916,626 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $14.9K | 805,246 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $11.7K | 892,782 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $9.5K | 288,356 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $8.4K | 334,741 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $6.5K | 408,462 | 0.0% |
| VCA Inc | COM | 918194101 | $6.4K | 91,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $5.6K | 45,410 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.1K | 336,759 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $4.8K | $4,000,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $4.5K | 510,369 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $4.4K | 1,425,158 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $3.8K | 575,863 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $818 | 27,539 | 0.0% |
| First TR Exchange Traded FD(FBT) | NY ARCA BIOTECH | 33733E203 | $308 | 3,090 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $255 | 1,820 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $246 | 1,390 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $216 | 2,460 | 0.0% |
| Achaogen Inc | COM | 004449104 | $155 | 32,300 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $91 | 22,236 | 0.0% |